Search - tctmd.com

Displaying 341 - 360 of 3565

Sort: Relevancy | Date

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

Presenter: Harriette G.C. Van Spall

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

Presentation THT 2024

Remote Patient Monitoring: Implications for Management of HF Patients During the Next Decade

Presenter: Akshay Desai

March 05, 2024

Presentation THT 2024

Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF

Presenter: Akshay Desai

March 05, 2024

Presentation THT 2024

BrioHealth Solutions: Pump and Clinical Trial Design

Presenter: James Long

March 04, 2024

Presentation Miami Valves 2024

Modern PCI: Achieve Optimal Treatment with AGENT DCB

Presenter: Yiannis S. Chatzizisis

February 03, 2024

Presentation Miami Valves 2024

AGENT™ Drug-Coated Balloon

Presenter: John M. Lasala

February 03, 2024

Presentation CTO 2024

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Presenter: Ajay J. Kirtane

February 03, 2024

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

Presentation Miami Valves 2024

AGENT DCB Clinical Data

Presenter: Nicolas M. Van Mieghem

February 01, 2024

Presentation Cardiovascular Interventions 2023

Building Your PERT Team: Designing the Right Team with the Right Technology

Presenter: Curtiss T. Stinis

November 10, 2023

Presentation Cardiovascular Interventions 2023

Conversations in Cardiology Decisions Are Not Always Black and White

Presenter: Morton J. Kern

November 10, 2023

Presentation Cardiovascular Interventions 2023

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

Presenter: Ajay J. Kirtane

November 10, 2023

Presentation Cardiovascular Interventions 2023

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

Presenter: Paul S. Teirstein

November 10, 2023

Presentation Cardiovascular Interventions 2023

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Presenter: Ajay J. Kirtane

November 10, 2023

Presentation TCT 2023

Understanding the Magnitude and Importance of TAVR Complications in Modern Clinical Practice

Presenter: Nimesh Desai

October 26, 2023

Presentation TCT 2023

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Presenter: Haibo Jia

October 26, 2023

Presentation TCT 2023

Aortic (Mis) Adventures: Nightmares From the Aortic Annulus, Root and Arch

Presenter: Nimesh Desai

October 26, 2023

Presentation TCT 2023

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Presenter: Tobias Koch

October 26, 2023

Advertisement

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Designing Clinical Trials to Facilitate Better Implementation: Tips for Researchers

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Remote Patient Monitoring: Implications for Management of HF Patients During the Next Decade

Inhibition of Hepatic Angiotensinogen Synthesis by an RNA Interference Therapeutic Agent: Implications for HTN and HF

BrioHealth Solutions: Pump and Clinical Trial Design

Modern PCI: Achieve Optimal Treatment with AGENT DCB

AGENT™ Drug-Coated Balloon

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

AGENT DCB Clinical Data

Building Your PERT Team: Designing the Right Team with the Right Technology

Conversations in Cardiology Decisions Are Not Always Black and White

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Understanding the Magnitude and Importance of TAVR Complications in Modern Clinical Practice

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Aortic (Mis) Adventures: Nightmares From the Aortic Annulus, Root and Arch

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content